Immunology and Microbiology
Macrophage
100%
Pseudomonas aeruginosa
62%
Mouse
55%
Myeloid
42%
Pulmonary Inflammation
27%
Host Resistance
26%
Nontuberculous mycobacteria
25%
Gene Expression
24%
Bone Marrow-Derived Macrophage
22%
Immune Response
17%
Human Immunodeficiency Virus 1
17%
Prostaglandin
15%
Inflammation Response
14%
Neutrophil Granulocyte
14%
Innate Immune System
14%
Alveolar Macrophage
13%
Peroxisome
13%
Prostaglandin E2
12%
Exosome
12%
Transcription Factor Nrf2
12%
Infectious Agent
12%
TLR4
12%
Mediator
11%
Bioluminescence
11%
COVID-19
10%
Immunosuppressive Drug
10%
Human Immunodeficiency Virus
10%
Bacterial Clearance
10%
Leukocyte
9%
Neutrophil
9%
Unfolded Protein Response
8%
Monocyte
7%
Complement Factor B
7%
Host Factor
7%
Host-Pathogen Interaction
7%
Blood Brain Barrier
7%
Signal Transduction
7%
Bioenergy
7%
Blood Plasma
6%
Sarcoidosis
6%
Wild Type
6%
Lower Respiratory Tract
6%
Epigenetics
6%
Immunomodulation
5%
Macrophage Response
5%
Transgenics
5%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
5%
Rothia mucilaginosa
5%
Wiskott-Aldrich Syndrome
5%
Liver Transplantation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
51%
Pseudomonas aeruginosa
47%
Pneumonia
40%
Disease
37%
Adult Respiratory Distress Syndrome
33%
Inflammation
30%
Infection
28%
Injury
26%
Acute Lung Injury
24%
Nuclear Factor
23%
Lipopolysaccharide
23%
Alternative Complement Pathway C3 C5 Convertase
22%
Luciferase
20%
Metastasis
17%
Chronic Obstructive Lung Disease
16%
Mouse Model
15%
Lung Disease
15%
Transcription Factor Nrf2
14%
Pseudomonas Pneumonia
13%
Bacterial Infection
12%
Endotoxin
11%
Phosphotransferase
11%
Cyclooxygenase 2
10%
Placebo
10%
Alisma orientale
10%
Recurrent Disease
10%
Lipopolysaccharide-Induced Acute Lung Injury
10%
Interstitial Lung Disease
10%
Infectious Agent
10%
Dyspnea
9%
Immunosuppressive Agent
9%
Biological Marker
9%
Cystic Fibrosis
8%
Cytokine
8%
Peroxisome Proliferator Activated Receptor
8%
Host Factor
8%
Curcumin
8%
Reactive Oxygen Metabolite
8%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
7%
Therapeutic Effect
7%
Lung Cancer
7%
Hypoxemia
7%
Triggering Receptor Expressed on Myeloid Cells 1
7%
Sepsis
6%
Lung Infection
6%
Experimental Animal
6%
Respiratory Tract Inflammation
6%
Sarcoidosis
6%
Disease Severity
6%
Tumor Growth
6%
Keyphrases
TREM-1
31%
Macrophages
29%
NF-B
26%
Host Defense
22%
Pseudomonas Aeruginosa (P. aeruginosa)
21%
Gene Expression
18%
Lung
17%
PU.1
17%
Airway Epithelium
16%
Cyclooxygenase-2
15%
Lipopolysaccharide
14%
Bacterial Infection
13%
Pneumonia
13%
Lung Inflammation
11%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
10%
P47phox
10%
Tuberculosis Relapse
10%
Nuclear factor-B
10%
Bronchiectasis
10%
Myeloid Differentiation Factor 88 (MyD88)
10%
Bioluminescence Imaging
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Acute Respiratory Distress Syndrome
10%
Chronic Obstructive Pulmonary Disease
9%
Prostaglandin D2 (PGD2)
9%
P. Aeruginosa Infection
8%
Inflammatory Lung Disease
8%
Bacterial Pathogens
8%
Inflammatory Response
7%
Pseudomonas
7%
Placebo
7%
Inflammation
7%
Bone Marrow-derived Macrophages
7%
Acute Lung Injury
7%
Neutrophilic Inflammation
7%
Patient Characteristics
7%
Host Response
6%
Sarcoidosis
6%
Lipopolysaccharide-induced
6%
Transcription Factor
6%
Phospholipid Micelles
6%
Luciferase
6%
Pseudomonas Aeruginosa Infection
5%
Phosphorylation
5%
Innate Immunity
5%
Prostaglandins
5%
Reactive Oxygen Species
5%
TLR Ligands
5%
Aralia Continentalis
5%
Induced Expression
5%
